Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1992 Nov;66(5):821–826. doi: 10.1038/bjc.1992.367

Effects of tumour cells on angiogenesis and vasoconstrictor responses in sponge implants in mice.

S P Andrade 1, Y S Bakhle 1, I Hart 1, P J Piper 1
PMCID: PMC1977997  PMID: 1384642

Abstract

The effects of tumour cells (Colon 26) on the development and response of new blood vessels to different vasoconstrictors (platelet activating factor; PAF, endothelin-1, angiotensin II, adrenalin and 5-hydroxytryptamine) have been investigated. Sponge implants in mice were used to host tumour cells while washout of 133Xe was employed to assess local blood flow in the implanted sponges. By 14 days after implantation the response of vessels in tumour-bearing implants to the various vasoconstrictors generally was decreased compared to that obtained in control sponge implants or adjacent normal skin. Thus at this time point the t1/2 for 133Xe washout from control sponges treated with adrenalin (0.5 micrograms) was 30 +/- 4 min whereas in tumour-bearing sponges it was 5 +/- 1 min. This decreased sensitivity in tumour vessels was probably not due to a complete lack of contractile elements since actin was demonstrated by immunohistochemistry around blood vessels in both types of implant. The results of the present study have shown that the pharmacological responses of blood vessels in a growing tumour, Colon 26, differed from the responses of vessels of a similar age in non-neoplastic tissue. These results appear to suggest that the different angiogenic stimuli released from tumour tissue may markedly influence pharmacological reactivity of newly formed blood vessels.

Full text

PDF
821

Images in this article

823Figure 1
on p.823

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrade S. P., Fan T. P., Lewis G. P. Quantitative in-vivo studies on angiogenesis in a rat sponge model. Br J Exp Pathol. 1987 Dec;68(6):755–766. [PMC free article] [PubMed] [Google Scholar]
  2. Chan R. C., Babbs C. F., Vetter R. J., Lamar C. H. Abnormal response of tumor vasculature to vasoactive drugs. J Natl Cancer Inst. 1984 Jan;72(1):145–150. doi: 10.1093/jnci/72.1.145. [DOI] [PubMed] [Google Scholar]
  3. Folkman J., Klagsbrun M. Angiogenic factors. Science. 1987 Jan 23;235(4787):442–447. doi: 10.1126/science.2432664. [DOI] [PubMed] [Google Scholar]
  4. Hirst D. G., Hirst V. K., Shaffi K. M., Prise V. E., Joiner B. The influence of vasoactive agents on the perfusion of tumours growing in three sites in the mouse. Int J Radiat Biol. 1991 Jul-Aug;60(1-2):211–218. doi: 10.1080/09553009114551861. [DOI] [PubMed] [Google Scholar]
  5. Intaglietta M., Myers R. R., Gross J. F., Reinhold H. S. Dynamics of microvascular flow in implanted mouse mammary tumours. Bibl Anat. 1977;(15 Pt 1):273–276. [PubMed] [Google Scholar]
  6. Jain R. K. Determinants of tumor blood flow: a review. Cancer Res. 1988 May 15;48(10):2641–2658. [PubMed] [Google Scholar]
  7. Kallman R. F., DeNardo G. L., Stasch M. J. Blood flow in irradiated mouse sarcoma as determined by the clearance of xenon-133. Cancer Res. 1972 Mar;32(3):483–490. [PubMed] [Google Scholar]
  8. Mahadevan V., Hart I. R. Divergent effects of flavone acetic acid on established versus developing tumour blood flow. Br J Cancer. 1991 Jun;63(6):889–892. doi: 10.1038/bjc.1991.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mattsson J., Alpsten M., Appelgren L., Peterson H. I. Influence of noradrenaline on local tumour blood flow. Eur J Cancer. 1980 Jan;16(1):99–102. doi: 10.1016/0014-2964(80)90114-0. [DOI] [PubMed] [Google Scholar]
  10. Mattsson J., Lilja J., Peterson H. I. Influence of vasoactive drugs on local tumor blood flow. Eur J Cancer Clin Oncol. 1982 Jul;18(7):677–684. doi: 10.1016/0277-5379(82)90214-0. [DOI] [PubMed] [Google Scholar]
  11. SCHOEFL G. I. STUDIES ON INFLAMMATION. III. GROWING CAPILLARIES: THEIR STRUCTURE AND PERMEABILITY. Virchows Arch Pathol Anat Physiol Klin Med. 1963 Nov 8;337:97–141. [PubMed] [Google Scholar]
  12. Stücker O., Vicaut E., Teisseire B. Hyper-responsiveness to 5-HT2 agonists by tumour-linked arterioles in mice: consequences for tumor growth. Int J Radiat Biol. 1991 Jul-Aug;60(1-2):237–241. doi: 10.1080/09553009114551921. [DOI] [PubMed] [Google Scholar]
  13. Suzuki M., Hori K., Abe I., Saito S., Sato H. Functional characterization of the microcirculation in tumors. Cancer Metastasis Rev. 1984;3(2):115–126. doi: 10.1007/BF00047659. [DOI] [PubMed] [Google Scholar]
  14. Thiede K., Momburg F., Zangemeister U., Schlag P., Schirrmacher V. Growth and metastasis of human tumors in nude mice following tumor-cell inoculation into a vascularized polyurethane sponge matrix. Int J Cancer. 1988 Dec 15;42(6):939–945. doi: 10.1002/ijc.2910420625. [DOI] [PubMed] [Google Scholar]
  15. Tsuruo T., Yamori T., Naganuma K., Tsukagoshi S., Sakurai Y. Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. Cancer Res. 1983 Nov;43(11):5437–5442. [PubMed] [Google Scholar]
  16. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989 Dec 1;49(23):6449–6465. [PubMed] [Google Scholar]
  17. Wickersham J. K., Barrett W. P., Furukawa S. B., Puffer H. W., Warner N. E. An evaluation of the response of the microvasculature in tumors in C3H mice to vasoactive drugs. Bibl Anat. 1977;(15 Pt 1):291–293. [PubMed] [Google Scholar]
  18. Young S. W., Hollenberg N. K., Kazam E., Berkowitz D. M., Hainen R., Sandor T., Abrams H. L. Resting host and tumor perfusion as determinants of tumor vascular responses to norepinephrine. Cancer Res. 1979 Jun;39(6 Pt 1):1898–1903. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES